Quarterly report pursuant to Section 13 or 15(d)

Note Payable - Additional Information (Detail)

v3.5.0.2
Note Payable - Additional Information (Detail)
 3 Months Ended 6 Months Ended 9 Months Ended
Apr. 22, 2016
USD ($)
Jun. 30, 2015
USD ($)
Installments
May 31, 2016
USD ($)
May 31, 2016
USD ($)
Mar. 31, 2016
USD ($)
Nov. 30, 2015
USD ($)
Debt Instrument [Line Items]            
Note payable     $ 650,100 $ 650,100   $ 868,947
Notes payable, principal amount outstanding     0 0   $ 1,176,367
Debt instrument payment       875,774    
Gain on extinguishment of debt     300,593 300,593    
Notes Payable [Member]            
Debt Instrument [Line Items]            
Asset purchase agreement commencement date   Jul. 31, 2015        
Asset purchase agreement closing date   Jun. 30, 2019        
Notes payable, interest expense     7,874 22,265    
Asset Purchase Agreement [Member]            
Debt Instrument [Line Items]            
Note payable   $ 1,300,000        
Notes payable, principal amount outstanding     $ 1,300,000 $ 1,300,000    
Asset Purchase Agreement [Member] | CytoMedical [Member]            
Debt Instrument [Line Items]            
Debt instrument payment $ 778,287       $ 269,443  
Asset Purchase Agreement [Member] | Notes Payable [Member]            
Debt Instrument [Line Items]            
Number of monthly installments | Installments   48        
Repayment interval       Monthly    
Monthly installment amount   $ 29,938        
Annual interest rate   5.00%